INCY:NASDAQ
Incyte Corp
115,30 $
arrow_downward
-1,57%(-1,84) 1D
115,30 $
0,00% (0,00)
bedtimeAfter hours
Closed: 2 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
116,76 $
High
117,19 $
Low
114,57 $
Mkt. cap
23,37 млрд
Avg. vol.
1,45 млн
Volume
2,17 млн
P/E ratio
14,69
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,74
Shares outstanding
202,70 млн
No. of employees
3 мың
Open
116,76 $
High
117,19 $
Low
114,57 $
Mkt. cap
23,37 млрд
Avg. vol.
1,45 млн
Volume
2,17 млн
P/E ratio
14,69
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,74
Shares outstanding
202,70 млн
No. of employees
3 мың
News stories
From web sources and news partners
Investing.com Canada
·
1 сағат бұрын
Form 4 Incyte Corporation For: 2 October By Investing.com
News Corp
·
3 сағат бұрын
Incyte Corp. stock outperforms competitors despite losses on the day
MarketWatch
·
3 сағат бұрын
Incyte Corp. stock outperforms competitors despite losses on the day
Stock Titan
·
4 сағат бұрын
Shares replace quarterly director fees as Incyte (INCY) awards 206 fully vested shares.
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 мың
Founded2002
HeadquartersWilmington, Делавэр, Америка Құрама Штаттары
Sector-
Websiteincyte.com